Issue 13, 2020

Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications

Abstract

Nanobodies are antigen binding variable domains of heavy-chain antibodies without light-chains, and these biomolecules occur naturally in the serum of Camelidae species. Nanobodies have a compact structure and low molecular weight when compared with antibodies, and are the smallest active antigen-binding fragments. Because of their remarkable stability and manipulable characteristics, nanobodies have been incorporated into biomaterials and used as molecular recognition and tracing agents, drug delivery systems, molecular imaging tools and disease therapeutics. This review summarizes recent progress in this field focusing on nanobodies as versatile biomolecules for biomedical applications.

Graphical abstract: Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications

Article information

Article type
Review Article
Submitted
10 Apr 2020
Accepted
21 May 2020
First published
22 May 2020

Biomater. Sci., 2020,8, 3559-3573

Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications

X. Yu, Q. Xu, Y. Wu, H. Jiang, W. Wei, A. Zulipikaer, Y. Guo, Jirimutu and J. Chen, Biomater. Sci., 2020, 8, 3559 DOI: 10.1039/D0BM00574F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements